SERA vs XLV
Sera Prognostics Inc (SERA) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported SERA revenue for 2026-06-30 was $44.0K. Net income was -$17.5M. SERA currently screens at market cap $89.1M.
XLV does not have a complete income-statement cache yet.
SERA currently screens at market cap $89.1M. XLV currently screens at market cap $0.
Not investment advice. Open the SERA and XLV stock pages for the full models.
Not investment advice.